BRCA1 and BRCA2 germline mutations in Korean patients with sporadic breast cancer.

Jae Hong Seo, Dae Yeon Cho, Se Hyun Ahn, Kyung Sik Yoon, Chang Soo Kang, Hyun Mi Cho, Hyeon Sook Lee, Jae Jin Choe, Cheul Won Choi, Byung Soo Kim, Sang Won Shin, Yeul Hong Kim, Jun Suk Kim, Gil Soo Son, Jae Bok Lee, Bum Hwan Koo

Research output: Contribution to journalArticle

Abstract

In order to evaluate the role of BRCA1 and BRCA2 germline mutations in Korean patients with sporadic breast cancer, 97 patients with sporadic breast cancer were analyzed for mutations in the BRCA1 and BRCA2 coding regions, by using a combination of fluorescent-conformation sensitive gel electrophoresis (F-CSGE) and direct sequencing. Fifty-five distinct sequence variants were detected, which included three pathogenic truncating mutations, 15 missense mutations, 16 polymorphisms, and 21 intronic variants. Twenty-six of these variants have never been previously reported and may be of Korean-specific origin. Two pathogenic BRCA1 mutations (c.922_924delinsT, c.5445G>A) and one pathogenic BRCA2 mutation (c.2259delT) were observed, and two of these (BRCA1 c.5445G>A and BRCA2 c.2259delT) are novel. The total prevalence of germline pathogenic mutations in BRCA1 and/or BRCA2 in Korean sporadic breast cancer is estimated to be about 3.1%. Considering that the majority of breast cancer cases are sporadic, the present study will be helpful in the evaluation of the need for the genetic screening of germline BRCA mutations in sporadic breast cancer patients. Further study using a larger sample size is required to determine the merits of genetic diagnosis and counseling in breast cancer patients.

Original languageEnglish
JournalHuman Mutation
Volume24
Issue number4
Publication statusPublished - 2004 Oct 1

Fingerprint

Germ-Line Mutation
Breast Neoplasms
Mutation
Genetic Counseling
Genetic Testing
Missense Mutation
Sample Size
Electrophoresis
Gels

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)

Cite this

Seo, J. H., Cho, D. Y., Ahn, S. H., Yoon, K. S., Kang, C. S., Cho, H. M., ... Koo, B. H. (2004). BRCA1 and BRCA2 germline mutations in Korean patients with sporadic breast cancer. Human Mutation, 24(4).

BRCA1 and BRCA2 germline mutations in Korean patients with sporadic breast cancer. / Seo, Jae Hong; Cho, Dae Yeon; Ahn, Se Hyun; Yoon, Kyung Sik; Kang, Chang Soo; Cho, Hyun Mi; Lee, Hyeon Sook; Choe, Jae Jin; Choi, Cheul Won; Kim, Byung Soo; Shin, Sang Won; Kim, Yeul Hong; Kim, Jun Suk; Son, Gil Soo; Lee, Jae Bok; Koo, Bum Hwan.

In: Human Mutation, Vol. 24, No. 4, 01.10.2004.

Research output: Contribution to journalArticle

Seo, JH, Cho, DY, Ahn, SH, Yoon, KS, Kang, CS, Cho, HM, Lee, HS, Choe, JJ, Choi, CW, Kim, BS, Shin, SW, Kim, YH, Kim, JS, Son, GS, Lee, JB & Koo, BH 2004, 'BRCA1 and BRCA2 germline mutations in Korean patients with sporadic breast cancer.', Human Mutation, vol. 24, no. 4.
Seo JH, Cho DY, Ahn SH, Yoon KS, Kang CS, Cho HM et al. BRCA1 and BRCA2 germline mutations in Korean patients with sporadic breast cancer. Human Mutation. 2004 Oct 1;24(4).
Seo, Jae Hong ; Cho, Dae Yeon ; Ahn, Se Hyun ; Yoon, Kyung Sik ; Kang, Chang Soo ; Cho, Hyun Mi ; Lee, Hyeon Sook ; Choe, Jae Jin ; Choi, Cheul Won ; Kim, Byung Soo ; Shin, Sang Won ; Kim, Yeul Hong ; Kim, Jun Suk ; Son, Gil Soo ; Lee, Jae Bok ; Koo, Bum Hwan. / BRCA1 and BRCA2 germline mutations in Korean patients with sporadic breast cancer. In: Human Mutation. 2004 ; Vol. 24, No. 4.
@article{a032f3c452b245bfa188927a01313405,
title = "BRCA1 and BRCA2 germline mutations in Korean patients with sporadic breast cancer.",
abstract = "In order to evaluate the role of BRCA1 and BRCA2 germline mutations in Korean patients with sporadic breast cancer, 97 patients with sporadic breast cancer were analyzed for mutations in the BRCA1 and BRCA2 coding regions, by using a combination of fluorescent-conformation sensitive gel electrophoresis (F-CSGE) and direct sequencing. Fifty-five distinct sequence variants were detected, which included three pathogenic truncating mutations, 15 missense mutations, 16 polymorphisms, and 21 intronic variants. Twenty-six of these variants have never been previously reported and may be of Korean-specific origin. Two pathogenic BRCA1 mutations (c.922_924delinsT, c.5445G>A) and one pathogenic BRCA2 mutation (c.2259delT) were observed, and two of these (BRCA1 c.5445G>A and BRCA2 c.2259delT) are novel. The total prevalence of germline pathogenic mutations in BRCA1 and/or BRCA2 in Korean sporadic breast cancer is estimated to be about 3.1{\%}. Considering that the majority of breast cancer cases are sporadic, the present study will be helpful in the evaluation of the need for the genetic screening of germline BRCA mutations in sporadic breast cancer patients. Further study using a larger sample size is required to determine the merits of genetic diagnosis and counseling in breast cancer patients.",
author = "Seo, {Jae Hong} and Cho, {Dae Yeon} and Ahn, {Se Hyun} and Yoon, {Kyung Sik} and Kang, {Chang Soo} and Cho, {Hyun Mi} and Lee, {Hyeon Sook} and Choe, {Jae Jin} and Choi, {Cheul Won} and Kim, {Byung Soo} and Shin, {Sang Won} and Kim, {Yeul Hong} and Kim, {Jun Suk} and Son, {Gil Soo} and Lee, {Jae Bok} and Koo, {Bum Hwan}",
year = "2004",
month = "10",
day = "1",
language = "English",
volume = "24",
journal = "Human mutation.",
issn = "1098-1004",
publisher = "Wiley-Liss Inc.",
number = "4",

}

TY - JOUR

T1 - BRCA1 and BRCA2 germline mutations in Korean patients with sporadic breast cancer.

AU - Seo, Jae Hong

AU - Cho, Dae Yeon

AU - Ahn, Se Hyun

AU - Yoon, Kyung Sik

AU - Kang, Chang Soo

AU - Cho, Hyun Mi

AU - Lee, Hyeon Sook

AU - Choe, Jae Jin

AU - Choi, Cheul Won

AU - Kim, Byung Soo

AU - Shin, Sang Won

AU - Kim, Yeul Hong

AU - Kim, Jun Suk

AU - Son, Gil Soo

AU - Lee, Jae Bok

AU - Koo, Bum Hwan

PY - 2004/10/1

Y1 - 2004/10/1

N2 - In order to evaluate the role of BRCA1 and BRCA2 germline mutations in Korean patients with sporadic breast cancer, 97 patients with sporadic breast cancer were analyzed for mutations in the BRCA1 and BRCA2 coding regions, by using a combination of fluorescent-conformation sensitive gel electrophoresis (F-CSGE) and direct sequencing. Fifty-five distinct sequence variants were detected, which included three pathogenic truncating mutations, 15 missense mutations, 16 polymorphisms, and 21 intronic variants. Twenty-six of these variants have never been previously reported and may be of Korean-specific origin. Two pathogenic BRCA1 mutations (c.922_924delinsT, c.5445G>A) and one pathogenic BRCA2 mutation (c.2259delT) were observed, and two of these (BRCA1 c.5445G>A and BRCA2 c.2259delT) are novel. The total prevalence of germline pathogenic mutations in BRCA1 and/or BRCA2 in Korean sporadic breast cancer is estimated to be about 3.1%. Considering that the majority of breast cancer cases are sporadic, the present study will be helpful in the evaluation of the need for the genetic screening of germline BRCA mutations in sporadic breast cancer patients. Further study using a larger sample size is required to determine the merits of genetic diagnosis and counseling in breast cancer patients.

AB - In order to evaluate the role of BRCA1 and BRCA2 germline mutations in Korean patients with sporadic breast cancer, 97 patients with sporadic breast cancer were analyzed for mutations in the BRCA1 and BRCA2 coding regions, by using a combination of fluorescent-conformation sensitive gel electrophoresis (F-CSGE) and direct sequencing. Fifty-five distinct sequence variants were detected, which included three pathogenic truncating mutations, 15 missense mutations, 16 polymorphisms, and 21 intronic variants. Twenty-six of these variants have never been previously reported and may be of Korean-specific origin. Two pathogenic BRCA1 mutations (c.922_924delinsT, c.5445G>A) and one pathogenic BRCA2 mutation (c.2259delT) were observed, and two of these (BRCA1 c.5445G>A and BRCA2 c.2259delT) are novel. The total prevalence of germline pathogenic mutations in BRCA1 and/or BRCA2 in Korean sporadic breast cancer is estimated to be about 3.1%. Considering that the majority of breast cancer cases are sporadic, the present study will be helpful in the evaluation of the need for the genetic screening of germline BRCA mutations in sporadic breast cancer patients. Further study using a larger sample size is required to determine the merits of genetic diagnosis and counseling in breast cancer patients.

UR - http://www.scopus.com/inward/record.url?scp=16644380786&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=16644380786&partnerID=8YFLogxK

M3 - Article

C2 - 15365993

VL - 24

JO - Human mutation.

JF - Human mutation.

SN - 1098-1004

IS - 4

ER -